Overview

Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors

Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1 study to investigate the safety and activity of aldoxorubicin plus gemcitabine in Subjects with solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
CytRx
Treatments:
Doxorubicin
Gemcitabine